Medexus Pharmaceuticals Inc
Change company Symbol lookup
Select an option...
MEDXF Medexus Pharmaceuticals Inc
KIO KKR Income Opportunities Fund
BOAS BOA Acquisition Corp
ESBA Empire State Realty OP LP
ASGN ASGN Inc
CMS CMS Energy Corp
POWRU Powered Brands
VLDRW Velodyne Lidar Equity Warrants Exp 29 Sep 2025 *W EXP 09/29/2025
JPM JPMorgan Chase & Co
UVV Universal Corp
Go

Health Care : Pharmaceuticals | Small Cap Value
Based in Canada
Company profile

Medexus Pharmaceuticals Inc. is a Canada-based rare disease pharmaceutical company. The Company is a North American focused, specialty pharmaceutical business that operates through two divisions: Medexus Pharma Canada and Medexus Pharma USA. Medexus Pharma Canada, a fully integrated commercial infrastructure focused on rheumatology, allergy, auto-immune disease, specialty oncology and pediatric diseases in Canada. Medexus Pharma USA, a fully integrated commercial infrastructure focused on rheumatology and auto-immune diseases in the United States (U.S). The Company is focused on the therapeutic areas of auto-immune disease, hematology, pediatrics, dermatology and allergy. The Company's products are Rasuvo and Metoject, a formulation of methotrexate (auto-pen and pre-filled syringe) designed to treat rheumatoid arthritis and other auto-immune diseases. It also offers IXINITY, a medicine for use in patients 12 years of age or older with Hemophilia B and Rupall, an allergy medication.

Closing Price
$1.97
Day's Change
0.00 (0.00%)
Bid
--
Ask
--
B/A Size
--
Day's High
--
Day's Low
--
Volume
(Light)
Volume:
0

10-day average volume:
9,603
0

Display:

Providers:

UpdateCancel
6 providers
January 07, 2022
Medexus to Present at the H.C. Wainwright BioConnect 2022 Conference

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSX: MDP) (OTCQX: MEDXF) today announced that Ken d'Entremont, Chief Executive Officer of Medexus, and Marcel Konrad, Chief Financial Officer of Medexus, will be presenting at the H.C...(Globe Newswire)

December 06, 2021
Keynotes, Educational Panels and 70 Companies to Present at the SNN Network Canada Virtual Event on December 7-9, 2021

LOS ANGELES, CA / ACCESSWIRE / December 6, 2021 / The SNN Network Canada Virtual Event will take place on December 7-9, 2021, where 70 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global...(Accesswire)

December 02, 2021
Medexus to Participate in Two Upcoming Virtual Investor Conferences

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSX: MDP) (OTCQX: MEDXF) today announced that Ken d'Entremont, Chief Executive Officer of Medexus, and Marcel Konrad, Chief Financial Officer of Medexus, will be participating in two...(Globe Newswire)

Medexus Pharmaceuticals Announces Clear Path to FDA Decision Following medac's Type A Meeting with FDA on Treosulfan

NDA resubmission expected in second calendar quarter 2022 (previously anticipated timeline) Final FDA decision expected 2 to 6 months after NDA resubmission No additional Phase III study is required (Globe Newswire)

November 10, 2021
Medexus Pharmaceuticals Reports Financial and Operational Results for the Three- and Six-Month Periods Ending September 30, 2021

Achieved $17.9 million revenue driven by continued strength of Rupall(TM) Positioned for revenue growth along with expected recovery of IXINITY sales Commercially launched Trecondyv(treosulfan) in Canada (Globe Newswire)

Medexus to Present at the Q4 Investor Summit on November 17th

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSX: MDP) (OTCQX: MEDXF) today announced that management will present at the Q4 Investor Summit, hosted by the Investor Summit Group, being held virtually on November 16-17, 2021. (Globe Newswire)

November 08, 2021
Medexus Pharmaceuticals Announces Appointment of Internal Counsel

Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF) today announced that it has appointed Ian C Wildgoose Brown as the Company's general counsel and corporate secretary. In this role, Mr. Wildgoose Brown will work...(Globe Newswire)

Investor Summit Group Provides Update on Upcoming Q4 Virtual Summit

New York, New York--(Newsfile Corp. - November 8, 2021) - The Investor Summit Group, widely recognized for its reputation as the host of North America's largest independent investor conferences, will be hosting the upcoming Q4 Virtual Summit on...(Newsfile)

November 05, 2021
Sidoti Microcap Virtual Conference

A Conference Open to All Classes of Investors 70+ Companies Presenting and Meeting Interested Investors 1x1 Wednesday and Thursday, December 8-9, 2021 NEW YORK, NY / ACCESSWIRE / November 5, 2021 / Sidoti & Company, LLC has updated its...(Accesswire)

November 04, 2021
Medexus Schedules Second Quarter Fiscal 2022 Conference Call

Medexus Pharmaceuticals Inc. (the "Company" or "Medexus") (TSX: MDP) (OTCQX: MEDXF) today announced that it plans to host a conference call at 8:00 AM Eastern Time on Thursday, November 11, 2021 to discuss the Company's financial results for the...(Globe Newswire)

November 01, 2021
Medexus Pharmaceuticals Announces Type A Meeting with FDA Granted for Treosulfan

Medexus Pharmaceuticals Inc. ("Medexus" or the "Company") (TSX: MDP) (OTCQX: MEDXF) and medac GmbH ("medac") today announced that the U.S. Food and Drug Administration ("FDA") has granted a Type A meeting to medac for treosulfan, a bifunctional...(Globe Newswire)

Earnings Calendar and Events Data provided by |Terms of Use| © 2022 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., ,, and

Copyright © 2022. All rights reserved.